🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Once-daily combination Darunavir and ritonavir

Found 61 matching trials

B-free Multistage Trial

PHASE4

The primary objective of the study is to evaluate the efficacy of a booster...

Status

Enrolling By Invitation

Location

Cantonal Hospital Aarau

Start Date

2023-11-13

Trial ID

NCT06037564

Treatments Being Tested

DOR/DTG/3TC

A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients

PHASE2

The purpose of this study is to compare change of brachial artery flow medi...

Status

Completed

Location

Multiple Locations

Start Date

2009-06

Trial ID

NCT01391013

Treatments Being Tested

Darunavir(DRV)Ritonavir 2 nucleoside reverse transcriptase inhibitors (NRTIs)

A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

PHASE4

The goal of this clinical study is to provide continued access to the study...

Status

Recruiting

Location

Helios Salud

Start Date

2024-08-27

Trial ID

NCT06337032

Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants

PHASE3

The primary objective of this study is to evaluate the efficacy of switchin...

Status

Completed

Location

University of Alabama at Birmingham

Start Date

2018-08-28

Trial ID

NCT03631732

Treatments Being Tested

B/F/TAF NRTIs Third Agent

Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.

PHASE4

This is a research study into the effects of three drugs used to treat HIV ...

Status

Completed

Location

Holdsworth House Medical Practice

Start Date

2010-11

Trial ID

NCT01258439

Treatments Being Tested

raltegravir plus truvada Darunavir, ritonavir, tenofovir/emtricitabine (Truvada)

An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients

N/A

The purpose of this study is to evaluate tolerability of darunavir (PREZIST...

Status

Completed

Location

Multiple Locations

Start Date

2011-10

Trial ID

NCT01615601

Treatments Being Tested

darunavir (PREZISTA)etravirine (INTELENCE)ritonavir Other antiretroviral medications

Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

N/A

The purpose of this study was to evaluate the pharmacokinetic (PK) properti...

Status

Terminated

Location

Usc La Nichd Crs

Start Date

2021-09-01

Trial ID

NCT04518228

Treatments Being Tested

Bictegravir (BIC)Tenofovir alafenamide (TAF)Long-acting injectable formulation of cabotegravir (CAB LA)Dolutegravir (DTG)Atazanavir/ritonavir (ATV/r)Darunavir/ritonavir (DRV/r)Lopinavir/ritonavir (LPV/r)Cobicistat Ritonavir First-Line TB Treatment Second-Line TB Treatment Doravirine (DOR)

Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters

N/A

The U.S. Department of Health and Human Services (HHS) guidelines recommend...

Status

Completed

Location

USC CRS

Start Date

2009-06

Trial ID

NCT00851799

Treatments Being Tested

Emtricitabine/tenofovir disoproxil fumarate Ritonavir Atazanavir Raltegravir Darunavir

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1

PHASE3

The purpose of this study is to assess whether maraviroc administered once ...

Status

Terminated

Location

University of Alabama at Birmingham - 1917 Research Clinic

Start Date

2011-09

Trial ID

NCT01345630

Treatments Being Tested

Maraviroc Emtricitabine/tenofovir darunavir/ritonavir 800/100 mg placebo for emtricitabine/tenofovir placebo for maraviroc

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients

PHASE3

This study will evaluate the non-inferiority of Stribild® (elvitegravir/cob...

Status

Completed

Location

Spectrum Medical Group

Start Date

2011-11

Trial ID

NCT01475838

Treatments Being Tested

PI RTV FTC/TDF Stribild

Previous Next